Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04298541 · ClinicalTrials.gov registry record · Phase 2
Direct Comparison of Ga-68-DOTATATE and Ga-68-DOTATOC
A Phase 2 study, sponsored by Weill Medical College of Cornell University.
- Not yet
- Registry status
- Phase 2
- Development phase
- 6
- Enrollment target
NCT04298541: Clinical Trial Phase 2 study, sponsored by Weill Medical College of Cornell University.
NCT04298541 is a Phase 2 study that has not yet begun recruiting, run by Weill Medical College of Cornell University. The registered enrollment target is 6 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04298541, a Phase 2 study, has not yet begun recruiting, sponsored by Weill Medical College of Cornell University.
- NOT YET RECRUITING
- Registry status
- Phase 2
- Development phase
- 6 participants
- Enrollment target
Study Summary
The goal of this study is to propose the first direct comparison of Ga-68-DOTATATE PET/CT or PET/MR and Ga-68-DOTATOC PET/CT in patients with meningioma.
Interventions
- DRUG Ga-68- DOTATATE
- DRUG Ga-68-DOTATOC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2026-06 |
| Est. Completion | 2027-06 |
| Phase | Phase 2 |
What is known before NCT04298541 opens enrollment
NCT04298541 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Ga-68- DOTATATE is the first listed.
NCT04298541 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04298541 about?
NCT04298541 is a clinical study titled "Direct Comparison of Ga-68-DOTATATE and Ga-68-DOTATOC". The goal of this study is to propose the first direct comparison of Ga-68-DOTATATE PET/CT or PET/MR and Ga-68-DOTATOC PET/CT in patients with meningioma.
What is the current status of trial NCT04298541?
This trial is currently not yet recruiting. It is a Phase 2 study. The enrollment target is 6 participants. The study started on 2026-06. Estimated completion is 2027-06.
What interventions are being tested in trial NCT04298541?
The interventions under investigation include: Ga-68- DOTATATE (DRUG), Ga-68-DOTATOC (DRUG).
Who is sponsoring clinical trial NCT04298541?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04298541's enrollment target sits among peer trials
6 1996th of 2000 higher than 1 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia